BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 520360)

  • 1. Adrenal scintigraphy with 131I-19-iodochlesterol in the diagnosis of Cushing's syndrome associated with adrenal tumor.
    Barliev GB
    Eur J Nucl Med; 1979 Dec; 4(6):449-51. PubMed ID: 520360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome.
    Fig LM; Gross MD; Shapiro B; Ehrmann DA; Freitas JE; Schteingart DE; Glazer GM; Francis IR
    Ann Intern Med; 1988 Oct; 109(7):547-53. PubMed ID: 3421563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenal scintigraphy in Cushing's syndrome caused by bilateral hyperplasia, adenoma or carcinoma.
    Lindberg S; Ernest I; Fjälling M; Holmdahl C
    Nucl Med Commun; 1985 Jan; 6(1):31-6. PubMed ID: 3039430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas.
    Bardet S; Rohmer V; Murat A; Guillemot C; Maréchaud R; Chupin M; Lecomte P; Simon D; Delemer B; Schneebelli S; Beutter D; Jacquin V; Peltier P; Charbonnel B
    Clin Endocrinol (Oxf); 1996 May; 44(5):587-96. PubMed ID: 8762736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 131I-iodocholesterol (NP-59) scintigraphy in adrenocortical diseases.
    Taillefer R; Soucy JP; Eybalin MC; Levasseur A
    J Can Assoc Radiol; 1983 Jun; 34(2):120-4. PubMed ID: 6885882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A black adrenocortical adenoma causing Cushing's syndrome not imaged by radiocholesterol scintigraphy.
    Reschini E; Baldini M; Cantalamessa L
    Eur J Nucl Med; 1990; 17(3-4):185-7. PubMed ID: 2279500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenal incidentalomas showing unilateral concordant visualization by adrenocortical scintigraphy: comparison with adenomas in Cushing's syndrome.
    Tani A; Nakajo M; Tsuchimochi S; Nakabeppu Y; Umanodan T
    Ann Nucl Med; 2000 Jun; 14(3):205-12. PubMed ID: 10921486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary adrenocortical nodular dysplasia presented as adrenal adenoma by functional scintigraphy.
    García-Mayor RV; Pérez Mendez L; Páramo C; Andrade A; Guitian R; Butron M
    Clin Nucl Med; 1993 Mar; 18(3):220-2. PubMed ID: 8462213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited significance of asymmetric adrenal visualization on dexamethasone-suppression scintigraphy.
    Gross MD; Shapiro B; Freitas JE
    J Nucl Med; 1985 Jan; 26(1):43-8. PubMed ID: 2981301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nuclear medicine diagnostic localization in primary aldosteronism and Cushing syndrome].
    Sialer G; Marincek B; Mengden T; Vetter W
    Bildgebung; 1987-1989; 56(4):157-62. PubMed ID: 3078253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 131I-19-iodocholesterol scintigraphy of the adrenal cortex.
    Dige-Petersen H; Munkner T; Fogh J; Blichert-Toft M; Lund JO
    Acta Endocrinol (Copenh); 1975 Sep; 80(1):81-94. PubMed ID: 1173986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adrenal cortex scintigraphy with and without dexamethasone suppression in the study of primary aldosteronism].
    Milà López M; Castell-Conesa J; Pifarré Montaner P; Lorenzo Bosquet C; García-Burillo A; Porta Biosca F; Roca Bielsa I
    Rev Esp Med Nucl; 2004; 23(5):324-9. PubMed ID: 15450137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scintigraphy with 131I-19-iodocholesterol in adrenal disease.
    Jorgensen H; Norman N; Sundsfjord JA
    Acta Med Scand; 1975 May; 197(5):345-51. PubMed ID: 1146612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodocholesterol adrenal tissue uptake and imaging adrenal neoplasms.
    Schteingart DE; Seabold JE; Gross MD; Swanson DP
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1156-61. PubMed ID: 7229000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas.
    Katabami T; Ishii S; Obi R; Asai S; Tanaka Y
    Endocr J; 2016 Dec; 63(12):1123-1132. PubMed ID: 27616151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of adrenal venography and iodocholesterol scan in adrenal surgery.
    Herwig KR; Sonda LP
    J Urol; 1979 Jul; 122(1):7-8. PubMed ID: 458994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adrenocortical scintigraphy with 131I-19-iodocholesterol. Indications and results in 66 cases of hypercortisolism and hyperaldosteronism (author's transl)].
    Leger FA; Requeda E; Reach G; Plouin PF; Savoie JC
    Nouv Presse Med; 1981 Feb; 10(6):395-9. PubMed ID: 7220332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal cortical adenoma causing Cushing's syndrome: correct localization by functional scintigraphy despite nonlocalizing morphological imaging studies.
    Geatti O; Fig L; Shapiro B
    Clin Nucl Med; 1990 Mar; 15(3):168-71. PubMed ID: 2317996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal scintigraphy in the morphological and functional evaluation of Cushing's syndrome.
    Bui F; Macri' C; Varotto L; Boscaro M; Mantero F
    Cardiology; 1985; 72 Suppl 1():76-83. PubMed ID: 2996768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scanning of the adrenals in Cushing's syndrome.
    Gogas JG; Skalkeas GD; Sechas MN; Skandalakis PN
    Am Surg; 1987 Aug; 53(8):472-5. PubMed ID: 3605868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.